Cryoglobulinemia

What is Cryoglobulinemia?

Cryogloblinemia is a vasculitis of small blood vessels that is caused by deposition of immune complexes:  large aggregates of antibodies and the other proteins they are bound to.  Some other types of vasculitis are also caused by immune complexes, but cryoglobulinemia is defined by a laboratory test that identifies immune complexes that fall out of solution in the cold.  The severity of the disease is highly variable.  Skin, joints, and nerves are commonly affected.  Kidney disease is somewhat less common and with a wide range of severity.  The heart, brain, or gastrointestinal tract each are affected in fewer than 10% of cases.

Who gets Cryoglobulinemia?

Most patients with cryoglobulinemia are chronically infected with hepatitis C virus (HCV).  However, fewer than 3% of persons infected with HCV will develop cryoglobulinemic vasculitis, although the number of patients who test positive for cryoglobulins may be as high as 50%.   Many of the remaining patients with cryoglobulinemia have lupus, Sjogren’s syndrome, rheumatoid arthritis, or white blood cell cancers (lymphoma, myeloma, or Waldenstrom’s macroglobulinemia) as the underlying cause.  Development of cryoglobulinemia is rare among patients with these diseases.  Since all of these diseases can affect persons of both sexes and all ages, cryoglobulinemia affects a similar diversity of patients.

Symptoms

Most patients have weakness or fatigue, and many have sore joints or muscles.  The most common appearance of vasculitis in the skin is purpura (bright red circles, from the size of a pinhead up to half an inch, often painful or itchy), but open sores are also common.  Damage to nerves (neuropathy) causes numbness, tingling, severe burning pain, and or weakness in a hand or foot.  Involvement of the gastrointestinal organs causes abdominal pain.  Heart involvement could cause symptoms of a heart attack (chest pain) or congestive heart failure (difficulty breathing, swelling in the legs).  Brain involvement can cause strokes, including multiple small strokes, and might also cause headache.  Any symptoms that resolve within a few hours are unlikely to be caused by vasculitis.  Kidney disease causes no symptoms until severe kidney failure occurs.

Diagnosis

Most patients will have a biopsy of skin or nerve that shows vasculitis, or a kidney biopsy that shows a characteristic type of inflammation called membranoproliferative glomerulonephritis (MPGN).  In those settings, a positive blood test for cryoglobulins establishes the diagnosis of cryoglobulinemia.  In patients with syndromes highly suggestive of cryoglobulinemia, the blood test may allow diagnosis without biopsy.  The cryoglobulin test is difficult to do properly, since it requires that the tube of blood be transported and processed at body temperature.  For this reason, doctors are concerned about the possibility of a “false negative” cryoglobulin test and often order other tests that are usually but not always abnormal in cryoglobulinemia:  rheumatoid factor (usually positive), complement (usually with low C4 protein), and serum protein electrophoresis (SPEP, often shows evidence of a “monoclonal” antibody).  All patients with cryoglobulinemia should be tested for HCV infection.

Treatment

For patients with HCV, anti-viral therapy is indicated regardless of the degree of severity.  For less severe cases (e.g., purpura, weakness, and joint pain), anti-viral therapy alone is the treatment of choice.  Involvement of vital organs requires addition of immune-suppressive drugs.  Prednisone, azathioprine, and cyclophosphamide have been widely used, but recent studies have indicated that rituximab may be superior to these medications.  Cryoglobulinemia without HCV infection is also treated using these medications or methotrexate (which is not used in HCV-infected patients), but no comparison of treatments has been reported.  Patients with life-threatening or organ-threatening cryoglobulinemic vasculitis often receive plasmapheresis in addition to immune-suppressive medications.

Prognosis

For cryoglobulinemia associated with HCV, effective anti-viral therapy usually prevents recurrence of vasculitis.  If permanent damage to nerves or internal organs has not occurred, long-term prognosis is excellent.  For patients in whom anti-viral therapy cannot be used or is ineffective, or in patients without HCV, repeated or long-term therapy with immune-suppressive drugs may be needed.  Such treatment is usually effective in preventing further damage but has potentially serious side effects and requires regular monitoring by a doctor familiar with these medications.  Kidney disease in cryoglobulinemia is usually not severe enough to lead to dialysis, but since it can be, monitoring of kidney function is also important.

Revision: September 2012

Click here to get the Cryoglobulinemia brochure in PDF format

Key Resources:

Patient Advocacy Group(s):

 

About Author: joseph

Medical Search Tools

Enter your search terms in this tool and the results will open in a new tab or window.

Participation in Clinical Trials is one way you can help advance research into finding better treatments and perhaps even a cure for vasculitis!
Learn how you can participate in clinical trials - National Institutes of Health

Vasculitis Foundation Fellowship Program

The Vasculitis Foundation Fellowship provides the opportunity for one- or two- year tracks designed to support the training of physician scientists who wish to gain clinical expertise in vasculitis and who may also wish to pursue an investigational career in this field. The fellowship will be conducted through Vasculitis Centers where there has been a track record of training individuals in vasculitis.

"The Vasculitis Foundation is committed to creating greater awareness and interest in vasculitis," said Joyce Kullman, executive director of the VF. "We hope that our new Vasculitis Foundation Fellowship will encourage medical professionals to pursue careers in patient care and research linked to vasculitis."

The Vasculitis Foundation Fellowship is possible thanks to the generous support of Genentech, Inc., and Biogen Idec and many other generous individual and corporate donors. For more information on how you may donate to the Vasculitis Foundation Fellowship, visit the donate page.

Medical Institutions

The Vasculitis Foundation encourages vasculitis patients to seek expert medical care for diagnosis and treatment of the disease. The VF works closely with vasculitis experts and centers around the world to ensure patients have access to the most up-to-date medical care.

The Vasculitis Clinical Research Consortium (VCRC) is an integrated group of academic medical centers, patient support organizations, and clinical research resources dedicated to conducting clinical research in different forms of vasculitis and improving the care of patients with vasculitis.